News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
Specialty:
Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition:
English
Medscape
English
Deutsch
Español
Français
Português
UK
New
Univadis
Log In
Sign Up It's Free!
English Edition
Medscape
English
Deutsch
Español
Français
Português
UK
New
Univadis
X
Univadis
from
Medscape
Register
Log In
No Results
No Results
Tuesday, March 21, 2023
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
close
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
Log out
Cancel
From
Medscape Neurology
Medscape Medical News from the
Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2015
October 07 - 10, 2015; Barcelona, Spain
Conference News
ECTRIMS
Earnings Gap for Patients With MS Worse in Lower-Level Jobs
Medscape Medical News
, October 23, 2015
ECTRIMS
Teriflunomide Slows Brain Volume Loss in MS
Medscape Medical News
, October 21, 2015
ECTRIMS
Anti-LINGO Agent Promotes Remyelination in Optic Neuritis
Medscape Medical News
, October 19, 2015
ECTRIMS
Online Fatigue Self-Management Program Promising in MS
Medscape Medical News
, October 16, 2015
ECTRIMS
'Ground-Breaking' Ocrelizumab Data Dominate ECTRIMS
Medscape Medical News
, October 16, 2015
ECTRIMS
High Intake of Plant-based Fatty Acids May Lower MS Risk
Medscape Medical News
, October 14, 2015
ECTRIMS
Old Drug Has New Promise in MS
Medscape Medical News
, October 13, 2015
ECTRIMS
Alemtuzumab in MS: Still Looks Good at 5 Years
Medscape Medical News
, October 9, 2015
ECTRIMS
Vitamin D Supplements Improve Cognition in Patients With MS
Medscape Medical News
, October 9, 2015
ECTRIMS
First Data From Ocrelizumab Phase 3 Studies in MS
Medscape Medical News
, October 8, 2015
ECTRIMS
Suicide Rate Almost Double in Patients With MS
Medscape Medical News
, October 8, 2015
ECTRIMS
More Data on Daclizumab in MS: DECIDE Published
Medscape Medical News
, October 8, 2015
ECTRIMS
What's Hot at ECTRIMS 2015?
Medscape Medical News
, October 7, 2015
Medscape Neurology© WebMD, LLC
Perspectives
Exploring a New Mechanism of Action for MS Drugs
Andrew N. Wilner, MD
Ups and Downs in MS: The Latest Drug Data
Stephen Krieger, MD
A Promising New Dosing Schedule for Natalizumab
Andrew N. Wilner, MD
Previous Coverage
ACTRIMS/ECTRIMS 2014
ECTRIMS 2013
ECTRIMS 2012
Related Resource
Multiple Sclerosis News & Perspectives